Literature DB >> 2748602

Significant structural and functional change of an antigen-binding site by a distant amino acid substitution: proposal of a structural mechanism.

N C Chien1, V A Roberts, A M Giusti, M D Scharff, E D Getzoff.   

Abstract

To study the molecular basis for antibody diversity and the structural basis for antigen binding, we have characterized the loss of phosphocholine (P-Cho) binding both experimentally and computationally in U10, a somatic mutant of the antibody S107. Nucleotide sequencing of U10 shows a single base change in JH1, substituting Asp-101 with Ala, over 9 A distant from the P-Cho-binding pocket. Probing with antiidiotypic antibodies suggests local, not global, conformational changes. Computational results support a specific structural mechanism for the loss of P-Cho binding. The U10 mutation eliminates the charged interaction between Asp-101 and Arg-94, which allows the Arg-94 side chain to disrupt P-Cho binding sterically and electrostatically by folding into the P-Cho-binding site. These results specifically show the importance of the Arg-94 to Asp-101 side chain salt bridge in the heavy-chain CDR3 conformation and suggest that residues distant from the binding site play an important role in antibody diversity and inducible complementarity.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2748602      PMCID: PMC297657          DOI: 10.1073/pnas.86.14.5532

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  The Protein Data Bank: a computer-based archival file for macromolecular structures.

Authors:  F C Bernstein; T F Koetzle; G J Williams; E F Meyer; M D Brice; J R Rodgers; O Kennard; T Shimanouchi; M Tasumi
Journal:  J Mol Biol       Date:  1977-05-25       Impact factor: 5.469

2.  Somatic diversification of S107 from an antiphosphocholine to an anti-DNA autoantibody is due to a single base change in its heavy chain variable region.

Authors:  A M Giusti; N C Chien; D J Zack; S U Shin; M D Scharff
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

Review 3.  The chemistry and mechanism of antibody binding to protein antigens.

Authors:  E D Getzoff; J A Tainer; R A Lerner; H M Geysen
Journal:  Adv Immunol       Date:  1988       Impact factor: 3.543

4.  Structure and energetics of ligand binding to proteins: Escherichia coli dihydrofolate reductase-trimethoprim, a drug-receptor system.

Authors:  P Dauber-Osguthorpe; V A Roberts; D J Osguthorpe; J Wolff; M Genest; A T Hagler
Journal:  Proteins       Date:  1988

Review 5.  Timing, genetic requirements and functional consequences of somatic hypermutation during B-cell development.

Authors:  D Allen; A Cumano; R Dildrop; C Kocks; K Rajewsky; N Rajewsky; J Roes; F Sablitzky; M Siekevitz
Journal:  Immunol Rev       Date:  1987-04       Impact factor: 12.988

Review 6.  Somatic mutation in anti-phosphorylcholine antibodies.

Authors:  U V Malipiero; N S Levy; P J Gearhart
Journal:  Immunol Rev       Date:  1987-04       Impact factor: 12.988

Review 7.  Evolution of antibody variable region structure during the immune response.

Authors:  T Manser; L J Wysocki; M N Margolies; M L Gefter
Journal:  Immunol Rev       Date:  1987-04       Impact factor: 12.988

8.  The determination of binding constants for binding between carbohydrate ligands and certain proteins.

Authors:  M E Jolley; C P Glaudemans
Journal:  Carbohydr Res       Date:  1974-04       Impact factor: 2.104

9.  Mouse immunoglobulin heavy chains are coded by multiple germ line variable region genes.

Authors:  P Barstad; V Farnsworth; M Weigert; M Cohn; L Hood
Journal:  Proc Natl Acad Sci U S A       Date:  1974-10       Impact factor: 11.205

10.  Point mutations cause the somatic diversification of IgM and IgG2a antiphosphorylcholine antibodies.

Authors:  N C Chien; R R Pollock; C Desaymard; M D Scharff
Journal:  J Exp Med       Date:  1988-03-01       Impact factor: 14.307

View more
  14 in total

1.  Altered reactivity of immunoglobulin produced by human-human hybridoma cells transfected by pSV2-neo gene.

Authors:  H Tachibana; K Akiyama; S Shirahata; H Murakami
Journal:  Cytotechnology       Date:  1991-07       Impact factor: 2.058

2.  Atomic structures of wild-type and thermostable mutant recombinant human Cu,Zn superoxide dismutase.

Authors:  H E Parge; R A Hallewell; J A Tainer
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

3.  Antibody remodeling: a general solution to the design of a metal-coordination site in an antibody binding pocket.

Authors:  V A Roberts; B L Iverson; S A Iverson; S J Benkovic; R A Lerner; E D Getzoff; J A Tainer
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

4.  Mass spectrometric measurement of changes in protein hydrogen exchange rates that result from point mutations.

Authors:  R S Johnson
Journal:  J Am Soc Mass Spectrom       Date:  1996-06       Impact factor: 3.109

5.  Structural properties of a subset of nephritogenic anti-DNA antibodies.

Authors:  T Kieber-Emmons; M H Foster; W V Williams; M P Madaio
Journal:  Immunol Res       Date:  1994       Impact factor: 2.829

6.  Modulation of antibody affinity by a non-contact residue.

Authors:  J F Schillbach; R I Near; R E Bruccoleri; E Haber; P D Jeffrey; J Novotny; S Sheriff; M N Margolies
Journal:  Protein Sci       Date:  1993-02       Impact factor: 6.725

7.  Amino acid substitutions outside a preselected antigenic region in hemoglobin affect the binding to monoclonal antibodies obtained by immunization with the synthetic region.

Authors:  M Oshima; S Nakamura; M Z Atassi
Journal:  J Protein Chem       Date:  1993-08

8.  A novel computer algorithm improves antibody epitope prediction using affinity-selected mimotopes: a case study using monoclonal antibodies against the West Nile virus E protein.

Authors:  Galina F Denisova; Dimitri A Denisov; Jeffrey Yeung; Mark B Loeb; Michael S Diamond; Jonathan L Bramson
Journal:  Mol Immunol       Date:  2008-08-29       Impact factor: 4.407

9.  Enhancement and destruction of antibody function by somatic mutation: unequal occurrence is controlled by V gene combinatorial associations.

Authors:  C Chen; V A Roberts; S Stevens; M Brown; M P Stenzel-Poore; M B Rittenberg
Journal:  EMBO J       Date:  1995-06-15       Impact factor: 11.598

10.  Mutational analysis of an autoantibody: differential binding and pathogenicity.

Authors:  J B Katz; W Limpanasithikul; B Diamond
Journal:  J Exp Med       Date:  1994-09-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.